Chirag Girishbhai Patel

Chirag Girishbhai Patel

Active Director Director DIN 03256651
DIN 03256651 First appointment Apr 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Apr 2005
Shareholding value •••• Premium profile

About Chirag Girishbhai Patel

Data last updated:

Chirag Girishbhai Patel is a Director at Elikem Pharmaceuticals Private Limited (since 2005), Director at Elikem Healthcare Private Limited (since 2022) and Designated Partner at Kings Softprint Llp (since 2017). The companies operate in Pharma, Information Technology and Travel and Hospitality. The 2 current companies with reported revenue have a combined latest revenue of ₹31.09 Cr; the largest is Elikem Pharmaceuticals Private Limited at ₹26.94 Cr (FY 2025). Earlier, Chirag Girishbhai Patel was a Director at Galaxy Leisure Private Limited (2013–2016) and Director at Nickson Agricare Private Limited (2015) and 1 more.

DIN 03256651
Primary Designation Director
Industry Pharma
First Appointment 01 Apr 2005
Oldest Company Age 34 yrs
Largest company Elikem Pharmaceuticals Private Limited · ₹26.94 Cr (FY 2025)
Combined revenue ₹31.09 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Apr 20051992₹26.94 Cr (FY 2025)Active
Elikem Healthcare Private Limited U24290GJ2022PTC132107
Director19 May 20222022₹4.15 Cr (FY 2025)Active
Designated Partner08 Mar 20172017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Galaxy Leisure Private Limited U55101GJ2012PTC073055
Director10 Aug 20132012Active
Nickson Agricare Private Limited U01403GJ2012PTC072135
Director18 Sep 20152012Strike Off
Elikem Nutra Private Limited U85300GJ2020PTC115701
Director21 Aug 20202020₹4.95 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Elikem Healthcare Private Limited
Elikem Pharmaceuticals Private Limited
Kings Softprint Llp
Galaxy Leisure Private Limited
Premium access

Shareholding and investment profile for Chirag Girishbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chirag Girishbhai Patel

Chirag Girishbhai Patel currently holds 3 directorships: Elikem Pharmaceuticals Private Limited (Director, since 01 Apr 2005, revenue ₹26.94 Cr (FY 2025)); Elikem Healthcare Private Limited (Director, since 19 May 2022, revenue ₹4.15 Cr (FY 2025)); Kings Softprint Llp (Designated Partner, since 08 Mar 2017).

Chirag Girishbhai Patel was first appointed on 01 Apr 2005 as Director at Elikem Pharmaceuticals Private Limited. The most recent appointment on record is 19 May 2022 at Elikem Healthcare Private Limited.

The 2 current companies of Chirag Girishbhai Patel that report revenue have a combined latest revenue of ₹31.09 Cr: Elikem Pharmaceuticals Private Limited ₹26.94 Cr (FY 2025); Elikem Healthcare Private Limited ₹4.15 Cr (FY 2025).

Chirag Girishbhai Patel held 3 earlier board appointments: Galaxy Leisure Private Limited (Director, 10 Aug 2013 to 01 Jul 2016); Nickson Agricare Private Limited (Director, 18 Sep 2015 to 10 Oct 2015); Elikem Nutra Private Limited (Director, 21 Aug 2020 to 01 Sep 2020).

The current boards of Chirag Girishbhai Patel's companies include Prakashkumar Shivramdas Patel (Elikem Pharmaceuticals Private Limited), Pratik Girishbhai Patel (Elikem Pharmaceuticals Private Limited), Vasantbhai Ambalal Raval (Elikem Pharmaceuticals Private Limited), Kishankumar Rameshbhai Patel (Elikem Healthcare Private Limited), Dhaval Kiritbhai Patel (Kings Softprint Llp), Priyanka Dhaval Patel (Kings Softprint Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available